NUE heads into its July 30 earnings release with analysts racing to catch up to a stock that has already moved — and options traders still hedging hard despite a 14% week.
The analyst response to this week's rally has been swift and broad. Wells Fargo's Timna Tanners lifted her target to $297 from $283 this morning, maintaining Overweight. Barclays raised to $295 from $272, also holding Overweight. BMO Capital pushed to $295 from $285, keeping Outperform. All three actions landed today, after the stock had already closed at $265.62 — meaning the newly raised targets cluster between $295 and $297, implying roughly 11–12% further upside from here. UBS is the outlier: it raised to $256 from $224 on July 28, but that target now sits below the current price, reinforcing UBS's cautious Neutral stance. The mean consensus target across the Street is $279, which NUE has effectively drawn level with after this week's move. The consensus rating remains constructive — the analyst recommendation differential ranks in the 93rd percentile of the ORTEX universe — but the targets are now clustering tightly around spot rather than offering the 10–15% upside cushion they represented just a week ago.
Options traders remain more defensive than at any point this year, even as the stock has surged. The put/call ratio closed at 0.74 on July 28, still running more than three standard deviations above its 20-day average of 0.59 — the highest z-score reading in the past 52 weeks. That defensive posture preceded and survived a 14% rally, which is itself notable: investors are still paying up for downside protection with earnings due tomorrow, not unwinding the hedges. The PCR is approaching the 52-week high of 0.84. That is not the setup of a market that feels comfortable chasing at $265.
The lending market offers zero support for the bearish options story. Borrow availability is essentially unlimited — roughly 170 million shares are available to lend, and availability reads at the platform ceiling. Cost to borrow has fallen 37% over the past month to just 0.26%. Short interest has eased to 1.75% of the free float, down 5% on the week. There is no short-side pressure, no squeeze dynamic, and no supply constraint. The defensive options positioning stands in isolation — it is a pure earnings hedge, not a signal of an emerging short thesis.
The steel sector has moved strongly this week, but NUE's 14% gain still leads the pack among its closest peers. STLD added 11.2% and RS gained 8.1%. CLF surged 29.5% on the week, though that likely reflects its own idiosyncratic restructuring narrative rather than a read-through for Nucor. CMC and TX both gained roughly 4–10%. The EPS momentum factor scores support a constructive read: 90-day EPS momentum ranks in the 79th percentile. The forward earnings yield, at around 6.8%, reflects a PE of roughly 14.7x — up about 1.3 turns over the past month as the stock has re-rated higher. EV/EBITDA is running near 8.9x.
What to watch tomorrow is whether the actual Q2 print validates the speed of this re-rating — specifically whether NUE's guidance on non-residential construction demand and steel pricing through the second half of 2026 gives the newly raised Street targets a footing, or leaves the stock looking stretched against a still-hedged options book.
See the live data behind this article on ORTEX.
Open NUE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
